Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Carbidopa Impurity G

Carbidopa Impurity G

NA

DISCOVER
Citalopram desfluoro oxalate (rac)

Citalopram desfluoro oxalate (rac)

1093072-86-6

DISCOVER
Carnitine DL HCl

Carnitine DL HCl

461-05-2

DISCOVER
Cephalexine H2O

Cephalexine H2O

23325-78-2

DISCOVER
Cyproheptadine HCl 1/2 H2O

Cyproheptadine HCl 1/2 H2O

41354-29-4

DISCOVER
Choline citrate dihydrogen

Choline citrate dihydrogen

77-91-8

DISCOVER
Beta-Cholestanol

Beta-Cholestanol

80-97-7

DISCOVER
Candesartan

Candesartan

139481-59-7

DISCOVER
Capecitabine

Capecitabine

154361-50-9

DISCOVER
Cilastatin

Cilastatin

82009-34-5

DISCOVER
Clenbuterol HCl

Clenbuterol HCl

21898-19-1

DISCOVER
Climbazole

Climbazole

38083-17-9

DISCOVER